Anxiety Across the Lifespan: Practical Integration of Basic and Clinical Approaches
|Event Date/Time: Mar 04, 2010||End Date/Time: Mar 07, 2010|
|Abstract Submission Date: Sep 01, 2009|
The Annual Conference provides the best value for your clinical or research needs. You will have the opportunity to network with renowned anxiety disorders experts and learn about the latest treatments and groundbreaking research.
Nearly 700 health professionals and researchers â€” psychiatrists, psychologists, social workers, counselors, therapists, nurses, physicians, clinical researchers, and basic neuroscientists â€” are expected to attend. ADAA offers up to 30 CE and CME credits.
If you treat patients who have anxiety disorders or conduct research on anxiety and related disorders, you need to attend the ADAA Annual Conference. ADAA members receive a registration discount. Join ADAA.
PROGRAM OVERVIEW AND STATEMENT OF NEED
The Annual Conference of the Anxiety Disorders Association of America is designed to meet the educational needs of members and nonmember clinicians and researchers. Current data suggests that in any given year more than 40 million adults in the United States suffer from an anxiety disorder. Anxiety disorders are the most commonly diagnosed disorders in children. ADAA members are among the leading experts in the field of anxiety disorders. Many researchers identify the underlying mechanisms for these disorders and develop new treatment strategies, as well as conduct research on effectiveness. The desired results for the meeting are that attendees learn the latest developments in preclinical and clinical research, translate this knowledge to clinicians, and develop new skills and techniques to improve diagnosis, prevention, and treatment of anxiety disorders.
After participating in the 2010 ADAA Annual Conference, attendees should be able to:
* Recognize recent advances in diagnosis and treatments for anxiety and anxiety-related disorders and consider application to their practices.
* Understand research advances that affect the development of new treatments and may modify current treatment practices.
* Realize the importance of early intervention in successful treatment, as well as the impact of development on anxiety disorders.
* Discuss the neurobiological evidence for anxiety and anxiety-related disorders and its relevance to developing new approaches.
* Disseminate the latest information on best practices and new research.